Novo Nordisk A/S
Copenhagen : NOVO B

December 25, 2012 08:18 ET

Novo Nordisk A/S: Ryzodeg® (insulin degludec/insulin aspart) approved in Japan

BAGSVAERD DENMARK--(Marketwire - Dec 25, 2012) - Company announcement No 84 / 2012:

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE [HUG#1667087]

Contact Information

  • Novo Nordisk
    T. Tlf. +45 44 44 88 88
    F. Fax +45 44 44 49 05